101 related articles for article (PubMed ID: 2867552)
1. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
Bissette G; Nemeroff CB
Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Gruber SH; Nomikos GG; Mathé AA
Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
Waters SM; Konkoy CS; Davis TP
J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats.
Herman ZS; Trzeciak HI; Kowalski J; Obuchowicz E; Huzarska M
Pol J Pharmacol Pharm; 1991; 43(5):421-32. PubMed ID: 1688094
[No Abstract] [Full Text] [Related]
6. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain.
Kinkead B; Owens MJ; Nemeroff CB
Synapse; 1995 Jul; 20(3):244-8. PubMed ID: 7570356
[TBL] [Abstract][Full Text] [Related]
8. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
Cáceda R; Kinkead B; Nemeroff CB
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
[TBL] [Abstract][Full Text] [Related]
9. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
10. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
Stowe ZN; Bissette G; Nemeroff CB
Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
Kinkead B; Shahid S; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
[TBL] [Abstract][Full Text] [Related]
12. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
Ma J; Ye N; Cohen BM
Neuroscience; 2006 Sep; 141(3):1469-80. PubMed ID: 16781818
[TBL] [Abstract][Full Text] [Related]
13. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.
Hong JS; Yang HY; Fratta W; Costa E
J Pharmacol Exp Ther; 1978 Apr; 205(1):141-7. PubMed ID: 24732
[No Abstract] [Full Text] [Related]
14. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
Jenner P; Marsden CD
Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
[No Abstract] [Full Text] [Related]
15. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin, schizophrenia, and antipsychotic drug action.
Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
[TBL] [Abstract][Full Text] [Related]
17. DA2/NT receptor balance in the mesostriatal and mesolimbocortical systems after chronic treatment with typical and atypical neuroleptic drugs.
Giardino L; Calzà L; Piazza PV; Zanni M; Amato G
Brain Res; 1990 Nov; 532(1-2):140-5. PubMed ID: 1980851
[TBL] [Abstract][Full Text] [Related]
18. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
19. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
20. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
Höllt V
Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
